Pharmacology of the lower urinary tract

Annual Review of Pharmacology and Toxicology

Volumn 41, Issue , 2001, Pages 691-721

  De Groat, W C ^a   Yoshimura, N ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Central and peripheral nervous system; Neurotransmitters; Smooth muscle; Urethra; Urinary bladder; Urinary incontinence

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR AGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROPEPTIDE; NITRIC OXIDE; NORADRENALIN; OPIATE PEPTIDE; PERGOLIDE; PURINE RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; TAK 637; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BLADDER INNERVATION; BLADDER MUSCLE; BLADDER SPHINCTER; DETRUSOR DYSSYNERGIA; DRUG EFFECT; DRUG MECHANISM; HUMAN; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; POLYURIA; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SMOOTH MUSCLE; URETHRA FUNCTION; URGE INCONTINENCE; URINE INCONTINENCE; URINE RETENTION;

ANIMALS; HUMANS; NEUROTRANSMITTER AGENTS; URINARY TRACT INFECTIONS;

EID: 0035040830     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.41.1.691     Document Type: Review

References (205)

1. Neural control of the lower urinary tract
2. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues
3. Receptors for purines and pyrimidines
4. Purinergic and pyrimidinergic signalling
5. The activation of bladder wall afferent nerves
6. The dual, sensory and 'efferent' function of the capsaicinsensitive primary sensory neurons in the urinary bladder and urethra
7. Distribution and colocalization of calcitonin gene-related peptide, tachykinins and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder
8. Altered c-fos immunoreactivity and nitric oxide release after spinal injury
9. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes: A possible sensory mechanism?
10. Mechanical trauma to bladder epithelium liberates prostanoids which modulate neurotransmission in rabbit detrusor muscle
11. Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats
12. Purinergic sensory neurotransmission in the urinary bladder: An in vitro study in the rat
13. ATP and 2-methyl thio ATP activate bladder reflexes and induce discharge of bladder sensory neurones
14. A neurogenic basis for the overactive bladder
15. Effects of LY215490, a competitive α-amino-3-hydroxy-5-methylisooxazole-4-propionic acid (AMPA) receptor antagonist, on the micturition reflex in the rat
16. Role of spinal glutamatergic transmission in the ascending limb of the micturition reflex pathway in the rat
17. Role of glutamate and NMDA receptors in the descending limb of the spinobulbospinal micturition reflex pathway of the rat
18. Alterations by urethane of glutamatergic control of micturition
19. Voiding function: Relevant anatomy, physiology, pharmacology, and molecular aspects
20. Voiding dysfunction: Diagnosis, classification, and management
21. The future direction of neuro-urology drug research
22. Muscarinic receptor antagonists in the treatment of overactive bladder
23. Muscarinic acetylcholine receptor sub-types mediating urinary bladder contractility and coupling to GTP binding proteins
24. 3-receptors coupled to inositol phosphlipid hydrolosis in human detrusor smooth muscle cells
25. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo
26. M1 muscarinic receptor mediated facilitation of acetylcholine release in the rat urinary bladder but not in the heart
27. M1 muscarinic receptor facilitation of ACh and noradrenaline release in the rat urinary bladder is mediated by protein kinase C
28. 2+ channels in muscarinic receptor mediated facilitation of ACh and noradrenaline release in the rat urinary bladder
29. Function, signal transduction mechanisms, and plasticity of presynaptic muscarinic receptors in the urinary bladder
30. Prejunctional facilitatory and inhibitory modulation of parasympathetic nerve transmission in the rabbit urinary bladder
31. Prejunctional M-1 facilitory and M-2 inhibitory muscarinic receptors mediate rat bladder contractility
32. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: Involvement of the M-4 receptor subtype
33. Nicotine evokes nitric oxide release from urinary bladder epithelium
34. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: Expression and function in humans
35. Pharmacokinetics of an oral once-a-day controlled release oxybutynin formulation compared with immediate-release oxybutynin
36. Tolterodine - A new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical data
37. Tolterodine
38. 3 receptors
39. Atropine-resistant excitation of the urinary bladder: Possibility of transmission via nerves releasing a purine nucleotide
40. The biphasic response of rat vesical smooth muscle to ATP
41. The mechanism of action of putative non-adrenergic non-cholinergic transmitters on the rabbit urinary bladder
42. 3H]-α,βmethylene ATP in rat urinary bladder membranes
43. 3H]α,β-methylene ATP binding sites in urinary bladder and urethra of rat, guinea-pig and rabbit
44. Distribution of P2X receptors in the urinary bladder and the ureter of the rat
45. Characterization and chromosomal localization of a human P2X receptor from the urinary bladder
46. 4 receptor gene is alternatively spliced
47. The effects of purine nucleotides on transmission in vesical parasympathetic ganglia of the cat
48. Multiple P2X receptors on guinea pig pelvic ganglion neurons exhibit novel pharmacological properties
49. Pharmacological and molecular characterisation of P2X purinoceptors in rat pelvic ganglion neurons
50. Purinergic cation channels in neurons of rabbit vesical parasympathetic ganglia
51. Alterations in urothelium and bladder afferents in feline interstitial cystitis (FIC)
52. Effects of capsaicin and cyclophosphamide on the distension-dependent release of ATP into the lumen of the lower urinary tract
53. Release of ATP from guinea pig ureter during distension
54. Adenosine mediates a slow hyperpolarizing synaptic potential in autonomic neurones
55. Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate
56. 3-adrenoceptor in the human detrusor muscle
57. 3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: Analysis by molecular biological and pharmacological methods
58. 1A-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate
59. 1adrenergic receptor binding subtypes in human detrusor
60. Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle
61. 1 adrenoceptor subtypes in the human prostatic urethra
62. 1B adrenoceptors on intraurethral and blood pressure responses in conscious dogs and a pharmacodynamic assessment of in vivo prostatic selectivity
63. 1 adrenoceptor subtype mRNAs in human proximal urethra
64. Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder
65. 1 adrenoceptors in the rat urinary bladder
66. 1 adrenoceptors
67. 1 adrenoceptors
68. Contraction of urinary bladder by central norepinephrine originating in the locus coeruleus
69. Mediation of micturition reflex by central norepinephrine from the locus coeruleus in the cat
70. 1 adrenergic receptor-mediated excitation from the locus coeruleus of the sacral parasympathetic preganglionic neuron
71. Effect of 5HT receptor and adrenoceptor antagonists on micturition in conscious cats
72. 1 adrenoceptors
73. 1-adrenoceptor blockade
74. Spinal and peripheral mechanisms contributing to hyperactive voiding in spontaneously hypertensive rats
75. 2 adrenoceptors in micturition in normal conscious rats
76. Micturition reflexes in chronic spinalized cats: The underactive detrusor and detrusor-sphincter dyssynergia
77. Intrathecal clonidine for refractory detrusor hyperreflexia in spinal cord injured patients: A preliminary report
78. Experimental evidence for a central nervous system site of action in the effect of alpha-adrenergic blockers on the external urethral sphincter
79. 1 adrenergic receptor agonist prazosin
80. Dopamine D1 receptor-mediated inhibition of micturition reflex by central dopamine from the substantia nigra
81. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats
82. Bladder hyperreflexia induced in marmosets by 1-methyl-4-phenyl, 1,2,4,6-tetrahydropyridine
83. The dopamine D1 receptor agonist SKF 38393 suppresses detrusor hyperreflexia in the monkey with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
84. Therapeutic effects of dopamine D1/D2 receptor agonists on detrusor hyperreflexia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys
85. Dopminergic receptor subtypes that induce hyperactive bladder response in anesthetized rats
86. Dopaminergic mechanisms underlying bladder hyperactivity in rats with unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway
87. Glutamatergic and dopaminergic contributions to rat bladder hyperactivity following cerebral artery occlusion
88. Brain stem influences on the parasympathetic supply to the urinary bladder of the cat
89. Glutamate activation of neurons in cardiovascular re-active areas of the cat brain stem affects urinary bladder motility
90. Brainstem control of visceral afferent pathways in the spinal cord
91. Effects of m-chlorophenylpiperazine on penile and bladder function in rats
92. 2C receptors
93. Effects of serotonergic agonists on micturition and sexual function in the rat
94. Serotonergic modulation of spinal ascending activity and sacral reflex activity evoked by pelvic nerve stimulation in cats
95. 1A receptors in the modulation of micturition reflexes in the anesthetized rat
96. 1A receptor ligands on the micturition reflex in rats: Comparison with WAY 100635
97. 2 receptor-mediated facilitation of pudendal nerve reflexes in the anaesthetized cat
98. Changes in bladder tone during filling: Pharmacological aspects
99. 4 receptors in the human isolated detrusor muscle: Effects of indole, benzimidazolone and substituted benzamide agonists and antagonists
100. Urinary disorders associated with cisapride. Adverse Drug Reactions Advisory Committee
101. Effect of metoclopramide on diabetic neurogenic bladder
102. 4 receptors
103. The effect of glutamate antagonists on c-fos expression induced in spinal neurons by irritation of the lower urinary tract
104. Role of NMDA and AMPA glutamatergic transmission in spinal c-fos expression after urinary tract irritation
105. Unitary excitatory synaptic currents in preganglionic neurons mediated by two distinct groups of interneurons in neonatal rat sacral parasympathetic nucleus
106. Synaptic modulation associated with developmental reorganization of visceral reflex pathways
107. Non-NMDA glutamatergic excitatory transmission in the descending limb of the spinobulbospinal micturition reflex pathway in the rat
108. Different expressions of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid and N-methyl-D-aspartate receptor subunit mRNAs between visceromotor and somatomotor neurons of the rat lumbosacral spinal cord
109. Pharmacological modulation of the pontine micturition center
110. Supraspinal AMPA and NMDA glutamatergic transmission in the micturition reflex in the rat
111. The influence of anesthesia on the development of bladder hyperactivity following middle cerebral artery occlusion in the rat
112. Role of the forebrain in bladder overactivity following cerebral infarction in the rat
113. Involvement of central GABA receptors in the regulation of the urinary bladder function of anaesthetized rats
114. In vivo effects of γ-aminobutyric acid on the urinary bladder contraction accompanying micturition
115. The inhibitory effect of opioid peptides and morphine applied intrathecally and intracerebroventricularly on the micturition reflex in the cat
116. The spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats
117. Inhibitory postsynaptic currents and the effects of GABA on visually identified sacral parasympathetic preganglionic neurons in neonatal rats
118. Effect of intrathecal baclofen on bladder and sphincter function
119. Urodynamic studies after intrathecal administration of baclofen and morphine in dogs
120. Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology
121. The pontine micturition center projects to sacral cord GABA immunore-active neurons in the cat
122. Spinal and supraspinal control of urethral tone and pelvic floor muscles
123. Mechanisms underlying recurrent inhibition in the sacral parasympathetic outflow to the urinary bladder
124. Evidence for a strychnine-sensitive mechanism and glycine receptors involved in the control of urethral sphincter activity during micturition in the cat
125. Pharmacological manipulation of central micturition circuitry
126. Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids
127. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat
128. Regulation of urinary bladder capacity by endogenous opioid peptides
129. Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats
130. Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex
131. Role of intrathecal tachykinins for micturition in unanaesthetized rats with and without bladder outlet obstruction
132. Effects of neurokinin receptor antagonists on L-dopa induced bladder hyperactivity in normal conscious rats
133. 2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthetized rats
134. 2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo
135. Effects of TAK-637, a tachykinin receptor antagonist, on lower urinary tract function in the guinea pig
136. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury
137. Facilitatory effect of pituitary adenylate cyclase activating polypeptide on micturition in normal, conscious rats
138. Effect of PACAP on preganglionic neurons in neonate rat lumbosacral parasympathetic nucleus
139. Regional differences in the den sity and subtype specificity of endothelin receptors in rabbit urinary tract
140. Endothelin in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regulation
141. Endothelin-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: Calcium dependence and phosphoinositide hydrolysis
142. Parathyroid hormone-related protein in the rat urinary bladder: A smooth muscle relaxant produced locally in response to mechanical stretch
143. Mechanical stretch increases secretion of parathyroid hormone-related protein by cultured bladder smooth muscle cells
144. Differential distribution of nitric oxide synthase in neural pathways to the urogenital organs (urethra, penis, urinary bladder) of the rat
145. Neural control of urethral outlet activity in vivo: Role of nitric oxide
146. Increased expression of neuronal nitric oxide synthase (NOS) in dorsal rat ganglion neurons after systemic capsaicin administration
147. Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation
148. Topical spinal administration of a nitric oxide synthase inhibitor prevents the hyperreflexia associated with a rat model of persistent visceral pain
149. Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation
150. Capsaicin-induced bladder overactivity and nociceptive behaviour in conscious rats: Involvement of spinal nitric oxide
151. 2+ independent nitric oxide release from inflamed urinary bladder
152. Effect of chronic spinal cord injury on capsaicin-sensitive (CAP-S) afferent innervation of the urinary bladder and on nitric oxide (NO) release from the urothelium
153. Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections
154. Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine
155. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis
156. Prostanoids as local modulators of reflex micturition
157. Prostaglandin E2-induced bladder hyperactivity in normal, conscious rats: Involvement of tachykinins?
158. Pharmacological evaluation of the role of cyclooxygenase isoenzymes on the micturition reflex following experimental cystitis in rats
159. Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction
160. Obstruction stimulates COX-2 expression in bladder smooth muscle via increased mechanical stretch
161. Electrophysiological properties of the bladder
162. Calcium sparks in smooth muscle
163. Voltage-gated calcium channels in autonomic neuroeffector transmission
164. Frequency dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats
165. ATP channel opener with in vivo selectivity for urinary bladder
166. + channel opener, ZD6169, on volume and PGE2-stimulated bladder activity in conscious rats
167. ATP channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats
168. ATP channel opener, on the micturition reflex in the rat
169. +-channel opener, ZD6169, on volume and PGE2-stimulated bladder activity in conscious rats
170. + currents in rat dorsal root ganglion neurons innervating the urinary bladder
171. Bladder afferent pathway and spinal cord injury: Possible mechanisms inducing hyperreflexia of the urinary bladder
172. Increased excitability of afferent neurons innervating rat urinary bladder following chronic bladder inflammation
173. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy
174. Altered NGF regulation may link a genetic predisposition for hypertension with hyperactive voiding
175. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction
176. Nerve growth factor: From neurotrophin to neurokine
177. trkA, CGRP and IB4 expression in retrogradely labelled cutaneous and visceral primary sensory neurones in the rat
178. Sensitisation of visceral afferents by nerve growth factor in the adult rat
179. Effects of chronic nerve growth factor treatment on rat urinary bladder and bladder afferent neurons
180. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
181. The capsaicin receptor: A heat-activated ion channel in the pain pathway
182. Capsaicin, protons and heat: New excitement about nociceptors
183. The cloned capsaicin receptor integrates multiple pain-producing stimuli
184. Intravesical capsaicin and resiniferatoxin therapy: Spicing up the ways to treat the overactive bladder
185. Intravesical capsaicin for neurogenic bladder dysfunction
186. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia
187. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term followup
188. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction
189. Effects of spinal cord injury on neurofilament immunoreactivity and capsaicin sensitivity in rat dorsal root ganglion neurons innervating the urinary bladder
190. Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat
191. Effect of capsaicin on the micturition reflex in normal and chronic spinal cats
192. Intravesical capsaicin treatment of severe bladder pain: A randomized placebo controlled study
193. Intravesical treatment of overactive bladder
194. Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation: A c-fos study
195. Comparison of the effects of intravesical capsaicin and resiniferatoxin for treatment of detrusor hyperreflexia in patients with spinal cord injury
196. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients
197. Botulinum-A toxin as a treatment of detrusorsphincter dyssynergia: A prospective study in 24 spinal cord injury patients
198. Botulinum A-toxin detrusor injections in the treatment of detrusor hyperreflexia